SCHEMBL1482575

SCHEMBL1482575

CCn1cc(C(=O)O)c(=O)c2cccc(F)c21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 3/20 0.66
LMNA P02545 5/20 0.50
MEN1 O00255 1/20 0.50
ABCC4 O15439 1/20 0.50
PKM P14618 1/20 0.50
PTGS1 P23219 1/20 0.50
KMT2A Q03164 1/20 0.50
HPGD P15428 6/20 0.49
POLB P06746 1/20 0.49
TAAR1 Q96RJ0 1/20 0.49
TDP1 Q9NUW8 2/20 0.48
HSD17B10 Q99714 6/20 0.48
KDM4E B2RXH2 6/20 0.48
ALDH1A1 P00352 5/20 0.48
TSHR P16473 3/20 0.48
RAB9A P51151 1/20 0.48
DRD3 P35462 1/20 0.47
HIF1A Q16665 1/20 0.47
PMP22 Q01453 1/20 0.47
HTT P42858 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12484211 0.90 CHRM1 (0.53) CHRM1LMNAMEN1ABCC4PKM
SCHEMBL3230348 0.85 CHRM1 (0.72) CHRM1LMNA
SCHEMBL11795840 0.84 LMNA (0.54) CHRM1LMNAMEN1ABCC4PKM
SCHEMBL11405256 0.84 LMNA (0.51) CHRM1LMNAMEN1ABCC4PKM
SCHEMBL11800723 0.84 CHRM1 (0.48) CHRM1LMNAMEN1ABCC4PKM
SCHEMBL3234394 0.84 CHRM1 (0.86) CHRM1LMNAHTTNPSR1CNR2
SCHEMBL8160866 0.83 LMNA (0.53) CHRM1LMNAMEN1ABCC4PKM
SCHEMBL14747460 0.83 CHRM1 (0.72) CHRM1LMNARAB9A
SCHEMBL9148710 0.82 LMNA (0.55) CHRM1LMNAMEN1ABCC4PKM
SCHEMBL3234551 0.82 CHRM1 (0.67) CHRM1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293914-B2 4-OXO,1-4-dihydroquinoline M1 receptor positive allosteric modulators MERCK SHARP & DOHME CORP. (US) 2012-10-23 US disclosed
US-20110077220-A1 4-OXO,1-4-DIHYDROQUINOLINE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME CORP. 2011-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110077220-A1 4-OXO,1-4-DIHYDROQUINOLINE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS CHRM1, OPRM1, OPRL1 CHRM1 1/4885LMNA 4479/4885MEN1 3500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.